FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Arm patents



      
           
This page is updated frequently with new Arm-related patent applications. Subscribe to the Arm RSS feed to automatically get the update: related Arm RSS feeds. RSS updates for this page: Arm RSS RSS


Pyridine and piperidine derivatives and use thereof

Excelsior Medical

Medicant injection device

Date/App# patent app List of recent Arm-related patents
05/21/15
20150142479
 Method and system for drug prescription patent thumbnailnew patent Method and system for drug prescription
A method and system for estimating the best price for a prescription at a local pharmacy where both the patient and the physician are able to see the best prescription price and location of the pharmacy to make a healthcare choice.. .
Doc&i Inc.
05/21/15
20150142469
 Management of pharmacy kits patent thumbnailnew patent Management of pharmacy kits
A system for managing pharmacy kits comprises a reading station configured to read tag information from a plurality of radio frequency identification (rfid) tags associated with a pharmacy kit, and an information processing system operatively connected to the reading station and configured to receive the tag information from the reading station and determine a status of the pharmacy kit based on the tag information, a plurality of stored templates defining contents to be included in each of a plurality of pharmacy kits, and a plurality of kit records indicating the current contents of a plurality of pharmacy kits.. .
Kit Check, Inc.
05/21/15
20150142468
 Management of pharmacy kits patent thumbnailnew patent Management of pharmacy kits
A system for managing pharmacy kits comprises a reading station configured to read tag information from a plurality of radio frequency identification (rfid) tags associated with a pharmacy kit, and an information processing system operatively connected to the reading station and configured to receive the tag information from the reading station and determine a status of the pharmacy kit based on the tag information, a plurality of stored templates defining contents to be included in each of a plurality of pharmacy kits, and a plurality of kit records indicating the current contents of a plurality of pharmacy kits.. .
Kit Check, Inc.
05/21/15
20150142467
 Management of pharmacy kits patent thumbnailnew patent Management of pharmacy kits
A system for managing pharmacy kits comprises a reading station configured to read tag information from a plurality of radio frequency identification (rfid) tags associated with a pharmacy kit, and an information processing system operatively connected to the reading station and configured to receive the tag information from the reading station and determine a status of the pharmacy kit based on the tag information, a plurality of stored templates defining contents to be included in each of a plurality of pharmacy kits, and a plurality of kit records indicating the current contents of a plurality of pharmacy kits.. .
Kit Check, Inc.
05/21/15
20150142463
 Performance of pharmacy search based on a prescription card patent thumbnailnew patent Performance of pharmacy search based on a prescription card
According to one embodiment, a system includes a memory and one or more processors communicatively coupled to the memory. The processors are operable to receive, from a user, a selection associated with a search for a pharmacy.
International Medical Records Systems, Llc
05/21/15
20150142088
 Female undergarment with heating component patent thumbnailnew patent Female undergarment with heating component
A device and method is taught for providing thermo therapeutic relief through the positioning of a heating element at a predetermined position in association with a garment to support and sustain the heat generated by the heating element in a designated area. The invention more particularly relates to a method and a device for treating menstrual cramps by application of thermo therapeutic relief to specific areas associated with a woman's abdomen.
05/21/15
20150142078
 External, head-worn electrical stimulator for treating headache conditions patent thumbnailnew patent External, head-worn electrical stimulator for treating headache conditions
An external, head worn electrical nerve stimulation device is disclosed that includes a head band including inner and outer surfaces, and a plurality of holes each including an interior surface. The device also includes a plurality of mounting baskets disposed within the holes and each including a cylindrical retaining member, and a plurality of biasing arms extending from the interior surface to the retaining member.
05/21/15
20150142067
 System for corrective spinal surgery and  use patent thumbnailnew patent System for corrective spinal surgery and use
A pedicle screw locking system includes a reduction tube and a locking driver. The reduction tube includes an inner shaft, a pair of grips, a reduction sleeve, and a rotatable tube.
K2m, Inc.
05/21/15
20150142020
 Laparoscopic suturing instrument with perpendicular eccentric needle motion patent thumbnailnew patent Laparoscopic suturing instrument with perpendicular eccentric needle motion
A suture needle driving instrument comprises a shaft and an end effector. The end effector is located at the distal end of the shaft and includes a pair of needle grasping arms.
Ethicon Endo-surgery, Inc.
05/21/15
20150141945
 Disposable feminine hygiene utility patent thumbnailnew patent Disposable feminine hygiene utility
A disposable feminine hygiene utility (10), comprising: a sanitary napkin (12) to be placed between an undergarment (26) of a user and a user's body; a permeable longitudinal sleeve (14), connected to the sanitary napkin (12); an absorbent pillow (20), enclosed by the permeable longitudinal sleeve (14); and first and second wires (18), each connected to another end of the absorbent pillow (20), for adjusting a position of the absorbent pillow (20) in relation to the longitudinal sleeve (14), with reference to a feminine anatomic section.. .
05/21/15
20150141936
new patent

Retractable syringe with improved delivery efficiency and locking system


A plunger, a needle assembly and a retractable syringe comprising same are provided. The plunger comprises a plunger member and a plunger outer having a lock spring that prevents or impedes movement of the plunger member after needle retraction.
Unitract Syringe Pty Ltd
05/21/15
20150141934
new patent

Medicant injection device


A medicant injection device includes a compressible body, a tip, and an outer luer body. The compressible body has a proximal end, a distal end, and a plurality of bellows, and defines an inner cavity for holding a liquid medicant.
Excelsior Medical Corporation
05/21/15
20150141921
new patent

Multi-state alarm system for a medical pump


A medical fluid delivery system includes an infusion pump configured to deliver medical fluid to a patient according to at least one treatment parameter, and an alarm feature associated with the infusion pump, the alarm feature including (i) a first alarm signal associated with a first event relating to the at least one treatment parameter, (ii) a second alarm signal associated with a second event relating to the at least one treatment parameter, the second alarm signal discernable from the first alarm signal, and (iii) a snooze element configured to deactivate the first alarm signal after the first event has occurred and to enable the second alarm signal to be activated upon occurrence of the second event.. .
Baxter International Inc.
05/21/15
20150141785
new patent

Flexible multiple-arm diagnostic catheter


A medical probe includes a distal end and an elongate body for insertion into an organ of a patient. The distal end is connected to the elongate body and includes multiple arms that, when inserted into the organ, extend to form multiple respective spirals each having electrodes disposed thereon..
Biosense Webster (israel) Ltd.
05/21/15
20150141740
new patent

Distributed resonator


A device, including a vibratory apparatus having an actuator configured to generate vibrations upon actuation of the actuator, including plurality of lever arms, wherein the vibratory apparatus is configured such that at least a respective portion of respective lever arms of the plurality of lever arms move about at least one of a single or a respective hinge when the vibratory apparatus is generating vibrations.. .
Cochlear Limited
05/21/15
20150141678
new patent

Ionizable cationic lipid for rna delivery


R3 is a lower alkyl; and r4 and r5 are the same or different, each a lower alkyl; or a pharmaceutically acceptable salt thereof.. .
05/21/15
20150141669
new patent

Prodrug of fluorine-containing amino acid


Provided are a fluorine-containing amino acid prodrug represented by general formula (i) that makes a fluorine-containing amino acid which is a group 2 metabotropic glutamate receptor agonist into a prodrug, or a pharmaceutically acceptable salt thereof. More specifically, provided is a prodrug that increases the in vivo exposure and enhances the oral absorbability and other mucosal absorbability of a parent compound that acts on group 2 metabotropic glutamate receptors as an agent for the treatment or prevention of diseases in which group 2 metabotropic glutamate receptors are said to be involved, such as: schizophrenia, anxiety disorder and its related diseases, depression, bipolar disorder, epilepsy, developmental disorders, sleep disorders, and other neuropsychiatric diseases; and drug dependence, cognitive disorders, alzheimer's disease, huntington's chorea, parkinson's disease, movement disorders associated with muscular rigidity, cerebral ischemia, cerebral insufficiency, spinal cord disorders, cephalopathy, and other neurological diseases..
Taisho Pharmaceutical Co., Ltd.
05/21/15
20150141644
new patent

Pyrrolo[2,1-f][1,2,4]triazine compound, and preparation method and application thereof


The present invention relates to a pyrrolo[2,1-f][1,2,4]triazine compound, an isomer thereof or a pharmaceutically acceptable salt, ester or hydrate thereof, and a preparation method and application thereof. The pyrrolo[2,1-f][1,2,4]triazine compound has a structure expressed in general formula (i).
Shanghai Haihe Pharmaceutical Co., Ltd.
05/21/15
20150141631
new patent

Pyrazole derivative and use thereof for medical purposes


The present invention provides pyrazole derivatives, uses thereof for medical purposes and so on. More particularly, the present invention relates to pharmaceuticals useful for the prevention or treatment of constipation, which comprise as an active ingredient 3-(3-{4-[3-(β-d-glucopyranosyloxy)-5-isopropyl-1h-pyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)-2,2-dimethylpropionamide, or a pharmaceutically acceptable salt thereof.
Kissei Pharmaceutical Co., Ltd.
05/21/15
20150141520
new patent

Stabilized pharmaceutical compositions of fingolimod and process for preparation thereof


Stabilized pharmaceutical compositions comprising a s1p receptor modulator as an active agent(s), process of preparation and method of using the same are provided. The present invention also relates to stabilized pharmaceutical compositions comprising fingolimod, or pharmaceutically acceptable salts, esters, hydrates and solvates thereof, process of preparation and method of using the same..
05/21/15
20150141502
new patent

Inhibition of leukemic stem cells by pp2a activating agents


A method of inhibiting the growth of leukemic hematopoietic stem cells in a subject with leukemia is described. The method includes administering a therapeutically effective amount of a composition including a compound of formula i: i wherein r1 is independently selected from hydrogen and methyl; r2 is selected from the group consisting of 4,8-dimethyl-non-1-enyl, 4,8-dimethyl-nonyl, non-1-enyl, and nonanyl groups; x is a carboxyl, phosphonic, or sulfonic moiety, and n is an integer from 1 to 6, or a compound of formula ii: ii wherein r1 is a c6-c12 alkyl or c6-c12 alkoxy group; r2 is independently selected from the group consisting of hydrogen, methoxy, and hydroxyl; and r3 is an alkyl or cycloalkyl group; or a pharmaceutically acceptable salt thereof..
Ohio State Innvation Foundation
05/21/15
20150141476
new patent

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea


The present invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (i) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of, inter alia, rosacea.. .
Amderma Pharmaceuticals, Llc
05/21/15
20150141462
new patent

Pharmaceutical compositions and methods for treating drug addiction and preventing a drug relapse


The present invention relates to pharmaceutical compositions comprising (a) a pharmaceutically effective amount of an mglur5 positive allosteric modulator, derivative, prodrug or a pharmaceutically acceptable salt thereof; (b) a pharmaceutically effective amount of an agent selected from an nmda partial agonist or a glyt1 inhibitor, derivative, prodrug or a pharmaceutically acceptable salt thereof; and (c) a pharmaceutically acceptable carrier. The present invention also relates to methods for treating drug addiction and preventing a drug relapse in a patient.
Arizona Board Of Regents, For And On Behalf Of, Arizona State University
05/21/15
20150141459
new patent

Pharmaceutical compositions and administrations thereof


The present invention relates to pharmaceutical compositions comprising a compound of formula i in combination with one or both of a compound of formula ii and/or a compound of formula iii. The invention also relates to solid forms and to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of cftr mediated diseases, particularly cystic fibrosis..
Vertex Pharmaceuticals Incorporated
05/21/15
20150141454
new patent

Liquid pharmaceutical formulations of palonosetron


The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments..
Roche Palo Alto Llc
05/21/15
20150141449
new patent

Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof


The present invention relates in general to the field of organic chemistry and in particular to the preparation of n-(4-(4-fluorophenyl)-6-isopropyl-5-methylpyrimidin-2-yl)-n-methylmethanesulfonamide (i), n-(4-(4-fluorophenyl)-5-(bromomethyl)-6-isopropylpyrimidin-2-yl)-n-methylmethanesulfonamide (ii) and n-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-n-methylmethanesulfonamide (iii), key intermediates in preparation of rosuvastatin.. .
Lek Pharmaceuticals D.d.
05/21/15
20150141448
new patent

Topical ophthalmological pharmaceutical composition containing pazopanib


The present invention relates to topical ophthalmological pharmaceutical compositions containing pazopanib, a hydrate, solvate or pharmaceutically acceptable salt thereof or a polymorph thereof and its process of preparation and its use for treating ophthalmological disorders.. .
Bayer Healthcare Llc
05/21/15
20150141434
new patent

Pyridine and piperidine derivatives and use thereof


Or pharmaceutically acceptable salts, solvates, hydrates, or diastereomers thereof, wherein r1, r4, x, g, n, p, w1, w2, w3, w4, and the e ring are defined in the disclosure. In certain embodiments, the invention provides compounds of formulae ii-xiii as set forth supra.
05/21/15
20150141431
new patent

Pyrazinoisoquinoline compounds


Where the designation (r) indicates that the designated carbon has the (r) stereochemistry; and wherein z1 is hydrogen or fluorine; z2 is hydrogen, deuterium, or fluorine; z3 is deuterium; z4 is fluorine; m is an integer from 0 to 10; n is an integer from 0 to 2; provided that: the sum of m+n does not exceed 10; and when both z1 and z2 are hydrogen, the sum of m+n is greater than 0, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are beneficially treated by administering an antihelminthic agent, such as praziquantel..
05/21/15
20150141426
new patent

Dosage regimen for a pi-3 kinase inhibitor


The present invention relates to a dosage regimen for a phosphatidylinositol 3-kinase (pi3k) inhibitor compound of formula (i) or a pharmaceutically acceptable salt thereof. More specifically, the present invention relates to a dosage regimen for the treatment of patients suffering from a proliferative disease, such as, for example, cancer, with a phosphatidylinositol 3-kinase (pi3k) inhibitor compound of formula (i) or a pharmaceutically acceptable salt thereof..
05/21/15
20150141424
new patent

Ire-1alpha inhibitors


Compounds which directly inhibit ire-1α activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated ire1-dependent decay (ridd) and can be used as single agents or in combination therapies..
Mannkind Corporation
05/21/15
20150141421
new patent

6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors


Methods of inhibiting a receptor tyrosine kinase in a subject in need thereof. Methods of inhibiting the growth of a tumor cell in a subject in need thereof.
05/21/15
20150141419
new patent

Diaryl[a, g]quinolizidine compound, preparation method therefor, pharmaceutical composition, and uses thereof


The present invention relates to a diarylo[a,g]quinolizidine compound of formula (i), enantiomer, diastereoisomer, racemate, mixture, pharmaceutically acceptable salt, crystalline hydrate or solvate thereof; the preparation method thereof, and uses thereof in preparing an experimental model drugs related to dopamine receptors and 5-ht receptors or a medicament for treating or preventing a disease related to dopamine receptors and 5-ht receptors.. .
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences
05/21/15
20150141407
new patent

N-aryl unsaturated fused ring tertiary amine compounds, preparation method and anti-tumor applications thereof


The present invention relates to a compound of formula i or a pharmaceutically acceptable salt thereof, its preparation method, a pharmaceutical composition comprising the compound, and its use in manufacture of a medicament for treatment of a disease or disorder, wherein r1, r2, r5, r6, x, y, q, w, n1 and n2 are defined as those stated in the description.. .
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.l.a. China
05/21/15
20150141402
new patent

Purine derivatives


Or pharmaceutically acceptable salts thereof, wherein q, g, ring a, ring b, r1, r2, r3, r4, r5, r5a, r6, r7, r8, r9, r10, r11, r12, r13, r14, r15, r16, r17, r18, r19, r20, r21, r22, r23, r24, and m are defined herein. The novel purine derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals.
05/21/15
20150141400
new patent

Quinazolinedione derivative


The present invention relates to quinazolinedione derivatives represented by formula (i) or pharmaceutically acceptable salts thereof.. .
Chugai Seiyaku Kabushiki Kaisha
05/21/15
20150141399
new patent

Mek inhibitors and methods of their use


And pharmaceutically acceptable salts and solvates thereof. Such compounds are mek inhibitors and are useful in the treatment of proliferative diseases, such as cancer.
05/21/15
20150141380
new patent

Inhibitors of erk for developmental disorders of neuronal connectivity


A method of treating a subject at risk of or suspected of having fragile x syndrome or autism spectrum disorder associated with abnormalities of erk includes administering to the subject a therapeutically effective amount of at least one erk inhibiting compound that prevents abnormalities in neuronal connectivity, a prodrug thereof that is metabolisable to form the compound, or a pharmaceutically acceptable salt thereof.. .
Case Western Reserve University
05/21/15
20150141365
new patent

Uracyl spirooxetane nucleosides


The present invention relates to compounds of the formula i: including any possible stereoisomers thereof, wherein r9 has the meaning as defined herein, or a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other hcv inhibitors, in hcv therapy..
Janssen R&d Ireland
05/21/15
20150141357
new patent

Shikimate pathway inhibitors and the use thereof


Or pharmaceutically acceptable salts thereof. The present invention also provides a synergistic antibacterial composition containing compound.
05/21/15
20150141352
new patent

Bone loss preventing and bone regeneration or bone formation promoting pharmaceutical composition comprising muramyl dipeptide


The present invention relates to a bone regeneration or bone formation promoting pharmaceutical composition comprising muramyl dipeptide, an analogue thereof, a derivative thereof or a pharmaceutically acceptable salt thereof. In contrast to existing passive therapeutic agents which center on bone absorption suppression based on mechanisms for reducing osteoclast functionality, the composition comprising muramyl dipeptide of the present invention promotes the differentiation of osteoblasts, which are bone forming cells, and can advantageously be used in various diseases where bone formation is required as an active therapeutic agent that does not affect osteoclast..
Snu R&db Foundation
05/21/15
20150141351
new patent

Solid pharmaceutical compositions


The present invention features solid pharmaceutical compositions comprising compound 1 (or a pharmaceutically acceptable salt thereof), compound 2 (or a pharmaceutically acceptable salt thereof), and ritonavir (a pharmaceutically acceptable salt thereof), which are co-formulated in amorphous solid dispersion comprising a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant.. .
Abbvie Deutschland Gmbh & Co. Kg
05/21/15
20150141349
new patent

Method and composition for alleviating tumor symptoms


This invention relates to methods and compositions for treating carcinoid syndrome and other adverse symptoms associated with tumor-producing neuroendocrine tumors, said methods comprising administering a therapeutically effective amount of a vascular disrupting agent, or a pharmaceutically acceptable salt thereof, to a subject having a hormone producing neuroendocrine tumor. In preferred implementations, the vascular disrupting agent is combretastatin a-4 phosphate, combretastatin a-1 diphosphate, or a pharmaceutical acceptable salt thereof..
Angiogene Pharmaceuticals Ltd.
05/21/15
20150141323
new patent

Peptide-oligourea chimeric compounds and methods of their use


The present description provides compositions and methods for producing therapeutic oligomeric compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal.
05/21/15
20150141215
new patent

Hand adapter for resistance band


The present invention relates to exercise equipment and more particularly to a hand adapter for use with a resistance band, wherein the hand adapter provides an unobstructed gripping surface and transfers the band's resistive forces through the user's metacarpals, wrist, and forearm in a linear, compressive force which stabilizes the wrist throughout an exercise movement, thereby providing increase control and decreased likelihood of injury.. .
05/21/15
20150141213
new patent

Weighted sleeve


The present invention provides a weighted sleeve containing granular weighted material that may be worn on one's hand, wrist, and/or forearm to weight one's hand and limit or curtail hand shaking symptoms and to compress the hand, wrist, and/or forearm as to temporarily alleviate pain and improve blood circulation.. .
05/21/15
20150141210
new patent

Swimming resistance trainer


A swimmer's resistance trainer having a base frame comprising two long slide rail sides and two short bench mount sides attached to each other to form a generally rectangular form, a bench rail attached to the two short sides using a vertical mount that extends between an end of the bench rail and each short side; a padded bench mounted onto a pivotal bench mount mounted onto a slide body that slideably attached to the bench rail; a padded head support attached to a headrest body that is slideably attached to the bench rail; at least one slideable padded armrest attached to an arm support post attached to a slideable arm rest body slideably attached to at least one of the long slide rails of the base frame, the at least one padded armrest comprises an arm resistance mechanism.. .
Roxy Development, Llc
05/21/15
20150141207
new patent

Rowing stepper exercise apparatus


The present invention relates to an exercise apparatus operated in a seated position where foot operated pedals and arm operated handles follow linear paths. More particularly, the present invention relates to an exercise apparatus having separately supported pedals for the feet and arm exercise coordinated with motion of the feet.
05/21/15
20150140518
new patent

Training device


Disclosed is a portable target training device that offers a versatile means of conducting target training, which may be adapted for use on varying terrain, outdoors, indoors, in scenario training, and in conjunction with accessories that affect both the exterior and interior conditions of the training device. The present invention houses a plurality of targets and/or obstacles that may be positioned in a manner that suits users' requirements.
05/21/15
20150140254
new patent

Method and providing liquid-proof seams for corrugated elastic laminates and articles made therefrom


A liquid-proof seamed article including an elastic laminated panel and a corrugated elastic laminated panel joined at the sealing regions of the laminated panels is provided. In exemplary embodiments, both of the laminated panels are corrugated.
W. L. Gore & Associates, Inc.
05/21/15
20150140130
new patent

Treatment of neurological disorders


A treatment of a neurological disorder, including hypoxia, oxygen-glucose deprivation and acute brain trauma in a subject involves administering an effective amount of selenate or a pharmaceutically acceptable salt thereof to the subject. The treatment prevents incurring a symptom, holds in check a symptom or treats an existing symptom of the neurological disorder..
Velacor Therapeutics Pty Ltd
05/21/15
20150140111
new patent

Preparations of effervescent formulations comprising second and third generation cephalosporin and uses thereof


The invention relates to effervescent pharmaceutical dosage forms including cefdinir as the active agent, and their preparation. The invention also relates to effervescent formulations including ceftibuten and/or its pharmaceutically acceptable salts, hydrates, solvates, esters, amorphous and crystal forms and/or a combination thereof.
05/21/15
20150140109
new patent

Docetaxel-based prolonged-release cancer treatment drug


The present invention relates to the field of pharmacology and medicine, specifically to a new generation of anticancer drugs with the cytostatic action based on docetaxel. In the drug composition of the invention docetaxel is included in biodigestible stable nanoparticles.
Oy Filana Ltd
05/21/15
20150140104
new patent

Therapeutic polymeric nanoparticles and methods of making and using same


Described herein are polymeric nanoparticles that include a therapeutic agent which is 2-(3-((7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-yl)amino)-1h-pyrazol-5-yl)-n-(3-fluorophenyl)acetamide (also known as azd1152 hqpa) or a pharmaceutically acceptable salt thereof, and methods of making and using such therapeutic nanoparticles.. .
Astrazeneca Ab
05/21/15
20150140101
new patent

Solid oral compositions of silodosin


The present disclosure relates to solid oral compositions of silodosin or its pharmaceutically acceptable salt thereof. More particularly capsule compositions of silodosin with one or more pharmaceutically acceptable excipients and process for their preparation..
Hetero Research Foundation
05/21/15
20150140099
new patent

Novel dosage form and formulation of abediterol


A pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a delivered dose of aclidinium equivalent to about 322 micrograms aclidinium free base.. .
Almirall, S.a.
05/21/15
20150140095
new patent

Once-a-day oxycodone formulations


The invention is directed to sustained release formulations containing oxycodone or a pharmaceutically acceptable salt thereof which provide a mean c24/cmax oxycodone ratio of 0.6 to 1.0 or 0.7 to 1 after oral administration at steady state to patients and methods thereof.. .
Purdue Pharma L.p.
05/21/15
20150140094
new patent

Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof


A pharmaceutical composition comprising compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a cftr mediated disease such as cystic fibrosis. Methods for treating a patient in need thereof include administering an oral pharmaceutical formulation of compound 1 to the patient..
Vertex Pharmaceuticals Incorporated
05/21/15
20150140092
new patent

Coated drug delivery formulations


The invention relates generally to methods of making formulations for delivering biological agents to a patient. In one aspect, proliposomal drug-delivery systems for medicaments are provided.
Western University Of Health Sciences
05/21/15
20150140088
new patent

Spirosteroid systems acting as neuroprotective and anti-inflammatory agents


The present invention relates to the fields of chemistry and pharmacy and, in particular, to the production of novel molecular entities: esterane derivatives fused with spirostanes rings, acting upon the central nervous systems (cns). From diosgenin, a naturally occurring sapogenin, with some subsequent transformations thereof, spirosteroid derivatives of the i-iv general formula can be obtained, with a cyclopentaneperhydrophenantrene nucleus fused to a 25r-spirostanes nucleus.
05/21/15
20150140085
new patent

Formulations comprising ibrutinib


Oral pharmaceutical formulations of ibrutinib and/or a pharmaceutically acceptable salt thereof, methods for their administration, process of their production, and use of these formulations for the treatment of diseases treatable by ibrutinib such as cancer, inflammatory diseases, and autoimmune diseases.. .
Principia Biopharma Inc.
05/21/15
20150140083
new patent

Pharmaceutical formulation containing gelling agent


Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.. .
The P.f. Laboratories, Inc.
05/21/15
20150140070
new patent

Lipid formulations for delivery of messenger rna


Or a pharmaceutically acceptable salt thereof.. .
05/21/15
20150140046
new patent

Compounds which inhibit neuronal exocytosis


Compounds of general formula (i): r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-aa7-aa8-aa9-yp-zq-r2 (i) their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, preparation processes, cosmetic or pharmaceutical compositions which contain them and their use in medicine, particularly in the treatment and/or prevention of pain, inflammation, itching, neurological, compulsive and/or neuropsychiatric diseases and/or disorders and in processes of treatment and/or care of the skin, hair and/or mucous membranes mediated by neuronal exocytosis.. .
Lubrizol Advanced Materials, Inc.
05/21/15
20150140029
new patent

Extracts from fusarium oxysporums and use thereof


Disclosed are the action and use of water extracts and polysaccharides from fusarium oxysporums in immune enhancement, which belong to the field of biological pharmacy. The water extracts and polysaccharides from fusarium oxysporums have a significant immune enhancement effect, which can promote the proliferation of macrophages, increase the phagocytic ability of macrophages, activate macrophages to release immunological active factors no, il-1α and tnf-α and can be used in lower immune function diseases and tumor adjuvant treatment..
University Of Macau, Av. Padre Tomas Pereira Taipa


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Arm for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Arm with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         











0.5657

5096

3 - 0 - 85